NASH mice displayed decreased HO-1 levels and HO activity, increased levels of hepatic heme, NOV, MMP2, hepcidin, and increased NAS scores and hepatic fibrosis. The gene discussed is HAMP; the disease is metabolic dysfunction-associated steatohepatitis.